IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality
<strong>Objectives</strong> We aimed to define the clinical and serological characteristics of pan-neurofascin antibody-positive patients. <br> <strong>Methods</strong> We tested serum from patients with suspected immune-mediated neuropathies for antibodies directed aga...
| Autori principali: | , , , , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
BMJ Publishing Group
2021
|